Results 41 to 50 of about 2,195 (197)
Infectious Diseases and Therapy, 2023 Introduction Zostavax, the live-attenuated vaccine used to prevent herpes zoster (HZ), has been available to individuals aged 70 and 71–79 years (phased catch-up) via Australia’s National Immunisation Program (NIP) since 2016.
Sachin Phakey +3 more
doaj +1 more source
Vaccines, 2022 Herpes Zoster (shingles) is an infection that occurs when varicella-zoster virus reactivates from the latent state. Incidence and severity of Herpes Zoster disease increase with age.
Andrea Ceccarelli +12 more
doaj +1 more source
A Quality Improvement Initiative to Manage Shingrix Vaccine Inventory in Ambulatory Clinics [PDF]
, 2020 Background: Inventory control practices for adult vaccines, specifically Shingrix, in ambulatory clinics are not well known or researched. This quality improvement project takes place at a small healthcare organization consisting of a hospital and ...
Colburn, Tracy
core +1 more source
13. Uncommon rash and neurological symptoms related to Shingrix [PDF]
Open Forum Infectious Diseases, 2020 Abstract Background Shingrix is a non-live recombinant vaccine approved by the Food and Drug Administration (FDA) in 2017 to prevent shingles and postherpetic neuralgia in immunocompetent adults age 50 years and older.
Yadava, sanjay K, Mahapatra, Rahul
openaire +1 more source
Association of asthma and herpes zoster, the role of vaccination: A literature review
Immunity, Inflammation and Disease, 2022 Herpes Zoster (HZ) is the reactivation of a previous infection with varicella‐zoster virus (VZV) which shares the same mode of transmission as HZ. It presents with painful erythematous vesicles in a dermatome which is characterized by a burning sensation
Abhigan Babu Shrestha +7 more
doaj +1 more source
Évaluation du vaccin Shingrix contre le Zona
, 2022 Le zona est une maladie douloureuse provoquée par une réactivation du virus de la varicelle. Dans la plupart des cas, il guérit spontanément en 2 à 4 semaines. Il peut toutefois avoir des complications, comme la névralgie post-herpétique (10 à 20 % des cas de zona), ou d’autres complications plus rares mais aussi plus graves.
Dominique, Roberfroid +3 more
openaire +1 more source
Natural and Synthetic Saponins as Vaccine Adjuvants
Vaccines, 2021 Saponin adjuvants have been extensively studied for their use in veterinary and human vaccines. Among them, QS-21 stands out owing to its unique profile of immunostimulating activity, inducing a balanced Th1/Th2 immunity, which is valuable to a broad ...
Pengfei Wang
doaj +1 more source
Shingrix: Educating Patients on the New Shingles Vaccine [PDF]
, 2018 Herpes zoster (shingles) is a viral infection that results in a painful rash and has a myriad of long-term complications, including post-herpetic neuralgia- chronic pain that does not resolved despite resolution of the rash.
Jost, Sarah Natasha
core +1 more source
Fatal Chronic Varicella‐Zoster Viral Infection in a Young Man With Chediak–Higashi Syndrome
Pediatric Dermatology, EarlyView.ABSTRACT Chediak–Higashi syndrome (CHS) is a rare autosomal recessive primary immunodeficiency characterized by partial oculocutaneous albinism, neurologic involvement, and a predisposition to severe infections. Patients are particularly susceptible to developing hemophagocytic lymphohistiocytosis (HLH), which significantly worsens prognosis. We report
Albane Badet +4 more
wiley +1 more source
Epi Update for Friday, April 13, 2018 [PDF]
, 2018 Weekly Newsletter for the Center for Acute Disease Epidemiology of the Iowa Department of Public ...
core